Grifols (GRFS) Interest & Investment Income (2010 - 2020)

Grifols (GRFS) posted Interest & Investment Income of $4.9 million for Q2 2018, down 94.57% quarter-over-quarter from $90.3 million in Q1 2018, and up 107.14% year-on-year from $2.4 million in Q2 2017.

Grifols (GRFS) Interest & Investment Income (2010 - 2020) Analysis & Trends

Grifols (GRFS) has reported Interest & Investment Income for 8 consecutive years, with $4.9 million the latest figure, recorded in Q2 2018.

  • Interest & Investment Income for Q2 2018 came in at $4.9 million, up 107.14% year-over-year; the trailing twelve-month figure through Jun 2018 was $164.3 million (down 12.01% YoY), and the FY2025 annual result was $39.6 million, down 15.83% from the prior year.
  • Interest & Investment Income was $4.9 million for Q2 2018 at Grifols, down from $90.3 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $114.5 million in Q4 2016 and troughed at $1.3 million in Q3 2015.
  • Average Interest & Investment Income over 4 years is $28.9 million, with a median of $2.8 million recorded in 2016.
  • Year-over-year, Interest & Investment Income soared 6525.3% in 2016 and gained 4.19% in 2017.
  • Over 4 years, Interest & Investment Income stood at $1.7 million in 2015, then jumped by 6525.3% to $114.5 million in 2016, then slumped by 97.93% to $2.4 million in 2017, then soared by 107.14% to $4.9 million in 2018.
  • Per Business Quant data, the three most recent Interest & Investment Income figures were $4.9 million in Q2 2018, $90.3 million in Q1 2018, and $2.4 million in Q2 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 229.00 Mn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -645.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 73.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Grifols - - - -

Historic Data

Download Data
DateValue
Mar 31, 2020 91.96 Mn
Dec 31, 2019 270.74 Mn
Mar 31, 2019 101.50 Mn
Dec 31, 2018 239.58 Mn
Sep 30, 2018 235.94 Mn
Jun 30, 2018 4.90 Mn
Mar 31, 2018 90.30 Mn
Dec 31, 2017 237.37 Mn
Jun 30, 2017 2.37 Mn
Mar 31, 2017 66.69 Mn
Dec 31, 2016 114.45 Mn
Sep 30, 2016 3.17 Mn
Jun 30, 2016 2.27 Mn
Mar 31, 2016 56.25 Mn
Dec 31, 2015 1.73 Mn
Sep 30, 2015 1.34 Mn
Jun 30, 2015 1.84 Mn
Mar 31, 2015 1.58 Mn
Dec 31, 2014 1.08 Mn
Sep 30, 2014 1.22 Mn